--- title: "Zoetis (NYSE:ZTS) Lowered to \"Strong Sell\" Rating by Zacks Research" type: "News" locale: "en" url: "https://longbridge.com/en/news/295651536.md" description: "Zacks Research downgraded Zoetis (NYSE:ZTS) from a 'hold' to a 'strong sell' rating. Other analysts also adjusted their views: Piper Sandler and Barclays lowered price targets, while William Blair maintained a 'market perform' rating. Despite recent earnings beating estimates, Zoetis faces mixed sentiment with an average Wall Street rating of 'Hold'. Institutional investors like Deutsche Bank and Pacer Advisors have increased their stakes." datetime: "2026-08-12T10:42:27.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295651536.md) - [en](https://longbridge.com/en/news/295651536.md) - [zh-HK](https://longbridge.com/zh-HK/news/295651536.md) --- # Zoetis (NYSE:ZTS) Lowered to "Strong Sell" Rating by Zacks Research Zoetis (NYSE:ZTS - Get Free Report) was downgraded by equities research analysts at Zacks Research from a "hold" rating to a "strong sell" rating in a research note issued to investors on Monday,Zacks.com reports. - Which Pet Stock Should Get Your Tail Wagging in 2024? A number of other equities research analysts have also recently weighed in on ZTS. William Blair restated a "market perform" rating on shares of Zoetis in a report on Thursday, August 6th. Piper Sandler lowered their target price on shares of Zoetis from $90.00 to $80.00 and set a "neutral" rating for the company in a report on Monday. TD Cowen dropped their price target on Zoetis from $150.00 to $104.00 and set a "buy" rating on the stock in a research report on Tuesday, June 30th. Wall Street Zen downgraded Zoetis from a "buy" rating to a "hold" rating in a research note on Saturday, May 2nd. Finally, Barclays reduced their price objective on Zoetis from $136.00 to $85.00 and set an "equal weight" rating for the company in a research report on Wednesday, July 1st. Eight equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $109.62. **Get Our Latest Analysis on Zoetis** ## Zoetis Stock Performance - MarketBeat Week in Review – 07/31 - 08/04 Shares of Zoetis stock opened at $75.23 on Monday. The company has a current ratio of 3.08, a quick ratio of 1.84 and a debt-to-equity ratio of 2.87. The firm has a market capitalization of $31.54 billion, a P/E ratio of 12.39, a P/E/G ratio of 1.29 and a beta of 0.73. The business has a fifty day simple moving average of $76.57 and a two-hundred day simple moving average of $99.89. Zoetis has a 12 month low of $71.45 and a 12 month high of $160.48. Zoetis (NYSE:ZTS - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $1.87 earnings per share for the quarter, topping analysts' consensus estimates of $1.85 by $0.02. The firm had revenue of $2.47 billion for the quarter, compared to the consensus estimate of $2.50 billion. Zoetis had a net margin of 27.49% and a return on equity of 74.89%. The company's revenue was down .2% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.76 EPS. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. On average, equities analysts forecast that Zoetis will post 6.19 earnings per share for the current fiscal year. ## Hedge Funds Weigh In On Zoetis - Rising Dividend Make Zoetis a Doggone Winner A number of hedge funds have recently added to or reduced their stakes in ZTS. Louisiana State Employees Retirement System purchased a new position in Zoetis in the 1st quarter worth about $2,542,000. Deutsche Bank AG boosted its holdings in shares of Zoetis by 19.1% during the 4th quarter. Deutsche Bank AG now owns 5,558,183 shares of the company's stock valued at $699,331,000 after acquiring an additional 891,921 shares during the last quarter. Pincus Capital Management LP bought a new stake in shares of Zoetis in the fourth quarter worth approximately $2,109,000. Highbridge Capital Management LLC purchased a new position in shares of Zoetis during the fourth quarter valued at approximately $7,004,000. Finally, Pacer Advisors Inc. lifted its position in Zoetis by 16.7% during the first quarter. Pacer Advisors Inc. now owns 165,570 shares of the company's stock valued at $19,572,000 after purchasing an additional 23,687 shares during the period. 92.80% of the stock is currently owned by hedge funds and other institutional investors. ## Zoetis News Roundup Here are the key news stories impacting Zoetis this week: - Positive Sentiment: Citigroup lowered its Zoetis price target from $112 to $96 but retained a **Buy** rating, implying substantial upside from recent levels. The continued Buy recommendation may provide support despite the more cautious valuation. Benzinga article - Positive Sentiment: BNP Paribas Exane cut its target from $146 to $110 while maintaining an **Outperform** rating. The target still indicates significant potential appreciation, suggesting the firm views recent weakness as excessive relative to Zoetis’ long-term prospects. Tickerreport.com article - Neutral Sentiment: JPMorgan reduced its Zoetis price target to $115, adding to the pattern of analysts recalibrating estimates without necessarily abandoning the investment case. JPMorgan price target article - Neutral Sentiment: Piper Sandler lowered its target from $90 to $80 and assigned a **Neutral** rating. The target remains modestly above the recent share price, but the stance signals limited near-term conviction. Benzinga article - Negative Sentiment: Recent coverage highlights leadership changes, competitive pressures and concerns surrounding Zoetis’ outlook. The company’s latest quarter also showed revenue down 0.2% year over year, while full-year 2026 EPS guidance of $6.15–$6.25 is below some analyst expectations, weighing on sentiment. ZTS Q2 Deep Dive article ## About Zoetis (Get Free Report) Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare. Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering. ## Read More - Five stocks we like better than Zoetis - Atlassian Just Pulled Off the Software Comeback Wall Street Wanted - AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be - NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings - Apple’s Next iPhone Could Test How Much Pricing Power Is Left _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ Continue following MarketBeat Add MarketBeat as your preferred source on Google to see our latest stories in your feed. Add As Preferred Source ## Should You Invest $1,000 in Zoetis Right Now? Before you consider Zoetis, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list. While Zoetis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [ZTS.US](https://longbridge.com/en/quote/ZTS.US.md) - [DB.US](https://longbridge.com/en/quote/DB.US.md) ## Related News & Research - [Zoetis Inc. $ZTS Stock Holdings Increased by Moran Wealth Management LLC](https://longbridge.com/en/news/296020852.md) - [Massachusetts Financial Services Co. MA Trims Stock Holdings in Zoetis Inc. $ZTS](https://longbridge.com/en/news/295998773.md) - [BLB&B Advisors LLC Sells 70,744 Shares of Zoetis Inc. $ZTS](https://longbridge.com/en/news/296015923.md) - [Fox Run Management L.L.C. Takes Position in Zoetis Inc. $ZTS](https://longbridge.com/en/news/295996530.md) - [Willis Investment Counsel Buys 31,787 Shares of Zoetis Inc. $ZTS](https://longbridge.com/en/news/295999719.md)